Elsiglutide

DRUG2 trials

Sponsors

Helsinn Healthcare SA

Conditions

DiarrheaDrug and/or Toxin-induced Diarrhea

Phase 2

Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea

CompletedNCT01543451

Helsinn Healthcare SADiarrhea

Start: 2012-02-29End: 2013-10-31Updated: 2014-03-26

Dose Finding Study in Colorectal Cancer Patients Receiving 5-FU-based Chemotherapy to Assess the Efficacy of Elsiglutide in the Prevention of Chemotherapy Induced Diarrhea (CID)

CompletedNCT02383810

Helsinn Healthcare SADrug and/or Toxin-induced Diarrhea

Start: 2015-01-31End: 2016-02-29Updated: 2024-03-01